Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | January 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |